Q2 2025 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2025-08-14 · accession 0000950123-25-008060
$369.2M
Reported value
8
Positions
2025-06-30
Period end
The Brief · FCPM III SERVICES B.V. · Q2 2025
AI · grounded in 13F
FCPM III SERVICES B.V. established a new position in NAMS valued at $192.5M. The fund also initiated stakes in DYN for $52M and REPL for $36.3M. Additional new positions include ENGENE HOLDINGS INC, BCYC, and CATBUSD.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $192.5M | 52.2% | 10,632,113 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $52.0M | 14.1% | 5,462,846 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $36.3M | 9.84% | 3,909,696 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $35.1M | 9.50% | 9,632,561 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $24.0M | 6.50% | 3,452,330 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $23.4M | 6.34% | 4,107,537 | Common | SHARED |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $3.5M | 0.93% | 440,176 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $2.4M | 0.64% | 2,878,148 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.